Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-067910
Filing Date
2025-03-31
Accepted
2025-03-31 08:41:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d939124d424b3.htm 424B3 22427
2 GRAPHIC g939120dsp4.jpg GRAPHIC 10306
3 GRAPHIC g939124g0317153912197.jpg GRAPHIC 3481
  Complete submission text file 0001193125-25-067910.txt   37496
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-279773 | Film No.: 25789111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)